This presentation will provide an update on our current understanding of glioblastoma. Specifically, Dr. Easaw will focus on current management and promising future therapies. He will also review recent significant updates in pathology that now provide a better understanding of the overall survival and response to treatment.
Presented by Dr. Jay Easaw
Dr. Jay Easaw is a Professor in the Division of Medical Oncology at the Cross Cancer Institute in Edmonton, Alberta. He is board certified in internal medicine and medical oncology. He is actively involved in both patient care and clinical research. Dr. Easaw’s research interests include metabolomics, database design, clinical informatics, and the introduction of technology into clinic. He is a recent recipient of awards in both teaching and research excellence.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Connect with Brain Tumour Foundation of Canada:
Facebook: / braintumourfdn
Twitter: / braintumourfdn​​​
Instagram: / braintumourfdn
Call Toll Free 1-800-265-5106 or locally 519-642-7755 - call with any questions and connect today!
Brain Tumour Foundation of Canada
205 Horton St E, Suite 203,
London, ON N6B 1K7
www.BrainTumour.ca​​​
Charitable Registration #BN118816339RR0001​​​
Copyright and Terms of Use Statement - Videos
Copyright of all videos created by Brain Tumour Foundation of Canada on this website, including the underlying HTML, text, illustrations, designs, icons, audio clips, video clips, documents, products, software and all other content is either owned by the Brain Tumour Foundation of Canada, or Brain Tumour Foundation of Canada has obtained a license to use the materials.
The videos on the site are protected by the Copyright Act. None of the videos may be copied, reproduced, distributed, republished, downloaded, or transmitted in any form or by any means, without the prior written consent of Brain Tumour Foundation of Canada, or the original creator, where applicable.
All information within the videos has been posted to provide Canadians affected by a brain tumour with support, education, information and an understanding of research programs or to thank donors and supporters for their contributions. The information has been posted with the intent that it be readily available for personal and public non-commercial (educational) use. The allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.